Class information for:
Level 1: CABAZITAXEL//ABIRATERONE//CASTRATION RESISTANT PROSTATE CANCER

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1969 2403 35.3 77%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
21 4 UROLOGY & NEPHROLOGY//UROL//JOURNAL OF UROLOGY 229838
272 3       PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL 43768
534 2             ANDROGEN RECEPTOR//PROSTATE CANCER//CASTRATION RESISTANT PROSTATE CANCER 14838
1969 1                   CABAZITAXEL//ABIRATERONE//CASTRATION RESISTANT PROSTATE CANCER 2403

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CABAZITAXEL authKW 1364998 6% 75% 144
2 ABIRATERONE authKW 1208355 6% 67% 142
3 CASTRATION RESISTANT PROSTATE CANCER authKW 1144243 9% 40% 226
4 ENZALUTAMIDE authKW 971835 5% 62% 124
5 ABIRATERONE ACETATE authKW 888428 4% 70% 100
6 METASTATIC CASTRATION RESISTANT PROSTATE CANCER authKW 698875 3% 72% 76
7 HORMONE REFRACTORY PROSTATE CANCER authKW 676582 4% 49% 108
8 HORMONE REFRACTORY authKW 437083 3% 43% 80
9 DOCETAXEL authKW 402635 14% 9% 335
10 ESTRAMUSTINE authKW 382588 3% 47% 64

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Urology & Nephrology 38274 37% 0% 886
2 Oncology 28165 56% 0% 1337
3 Pharmacology & Pharmacy 303 9% 0% 220
4 Andrology 266 1% 0% 17
5 Endocrinology & Metabolism 57 3% 0% 77
6 Medicine, General & Internal 35 4% 0% 87
7 Geriatrics & Gerontology 15 1% 0% 17
8 Health Care Sciences & Services 12 1% 0% 22
9 Hematology 10 1% 0% 36
10 Health Policy & Services 5 0% 0% 12

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 LANK GENITOURINARY ONCOL 103836 2% 21% 39
2 PROSTATE CANC TARGETED THER Y GRP 71559 1% 43% 13
3 GUSTAVE ROUSSY 58376 3% 7% 62
4 UROL ONCOL PROGRAM 53972 1% 25% 17
5 GENITOURINARY ONCOL SERV 52018 2% 10% 41
6 CAROLINA UROL 38110 0% 50% 6
7 MED ONCOL 34048 15% 1% 354
8 UROL 33835 23% 1% 544
9 GENITOURINARY CANC SECT 31264 0% 31% 8
10 DRUG DEV UNIT 27564 1% 10% 21

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CLINICAL GENITOURINARY CANCER 60246 2% 8% 57
2 EUROPEAN UROLOGY 17536 4% 1% 100
3 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 13532 2% 2% 45
4 PROSTATE 10323 3% 1% 61
5 JOURNAL OF CLINICAL ONCOLOGY 9362 5% 1% 110
6 BJU INTERNATIONAL 9170 3% 1% 77
7 UROLOGY 9148 5% 1% 109
8 PROSTATE CANCER AND PROSTATIC DISEASES 8547 1% 3% 27
9 EUROPEAN UROLOGY SUPPLEMENTS 6990 1% 3% 18
10 ANNALS OF ONCOLOGY 6843 3% 1% 67

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CABAZITAXEL 1364998 6% 75% 144 Search CABAZITAXEL Search CABAZITAXEL
2 ABIRATERONE 1208355 6% 67% 142 Search ABIRATERONE Search ABIRATERONE
3 CASTRATION RESISTANT PROSTATE CANCER 1144243 9% 40% 226 Search CASTRATION+RESISTANT+PROSTATE+CANCER Search CASTRATION+RESISTANT+PROSTATE+CANCER
4 ENZALUTAMIDE 971835 5% 62% 124 Search ENZALUTAMIDE Search ENZALUTAMIDE
5 ABIRATERONE ACETATE 888428 4% 70% 100 Search ABIRATERONE+ACETATE Search ABIRATERONE+ACETATE
6 METASTATIC CASTRATION RESISTANT PROSTATE CANCER 698875 3% 72% 76 Search METASTATIC+CASTRATION+RESISTANT+PROSTATE+CANCER Search METASTATIC+CASTRATION+RESISTANT+PROSTATE+CANCER
7 HORMONE REFRACTORY PROSTATE CANCER 676582 4% 49% 108 Search HORMONE+REFRACTORY+PROSTATE+CANCER Search HORMONE+REFRACTORY+PROSTATE+CANCER
8 HORMONE REFRACTORY 437083 3% 43% 80 Search HORMONE+REFRACTORY Search HORMONE+REFRACTORY
9 DOCETAXEL 402635 14% 9% 335 Search DOCETAXEL Search DOCETAXEL
10 ESTRAMUSTINE 382588 3% 47% 64 Search ESTRAMUSTINE Search ESTRAMUSTINE

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 SAVA, T , BASSO, U , PORCARO, A , CETTO, GL , (2005) NEW STANDARDS IN THE CHEMOTHERAPY OF METASTATIC HORMONE-REFRACTORY PROSTATE CANCER.EXPERT REVIEW OF ANTICANCER THERAPY. VOL. 5. ISSUE 1. P. 53-62 92 91% 5
2 MARTEL, CL , GUMERLOCK, PH , MEYERS, FJ , LARA, PN , (2003) CURRENT STRATEGIES IN THE MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER.CANCER TREATMENT REVIEWS. VOL. 29. ISSUE 3. P. 171-187 99 66% 63
3 SHELLEY, M , HARRISON, C , COLES, B , STAFFURTH, J , WILT, TJ , MASON, MD , (2006) CHEMOTHERAPY FOR HORMONE-REFRACTORY PROSTATE CANCER.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - 77 80% 17
4 MARTEL, CL , GUMERLOCK, PH , MEYERS, FJ , LARA, PN , (2004) CURRENT STRATEGIES IN THE MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER.ANNALES D UROLOGIE. VOL. 38. ISSUE 3. P. 85-102 99 66% 0
5 MCKEAGE, K , (2012) DOCETAXEL A REVIEW OF ITS USE FOR THE FIRST-LINE TREATMENT OF ADVANCED CASTRATION-RESISTANT PROSTATE CANCER.DRUGS. VOL. 72. ISSUE 11. P. 1559 -1577 57 83% 16
6 LORENTE, D , MATEO, J , PEREZ-LOPEZ, R , DE BONO, JS , ATTARD, G , (2015) SEQUENCING OF AGENTS IN CASTRATION-RESISTANT PROSTATE CANCER.LANCET ONCOLOGY. VOL. 16. ISSUE 6. P. E279 -E292 47 71% 25
7 DI LORENZO, G , DE PLACIDO, S , (2006) HORMONE REFRACTORY PROSTATE CANCER (HRPC): PRESENT AND FUTURE APPROACHES OF THERAPY.INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. VOL. 19. ISSUE 1. P. 11-33 69 77% 32
8 BASCH, E , LOBLAW, DA , OLIVER, TK , CARDUCCI, M , CHEN, RC , FRAME, JN , GARRELS, K , HOTTE, S , KATTAN, MW , RAGHAVAN, D , ET AL (2014) SYSTEMIC THERAPY IN MEN WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: AMERICAN SOCIETY OF CLINICAL ONCOLOGY AND CANCER CARE ONTARIO CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 32. ISSUE 30. P. 3436 -U133 40 83% 45
9 SONPAVDE, G , WANG, CG , GALSKY, MD , OH, WK , ARMSTRONG, AJ , (2015) CYTOTOXIC CHEMOTHERAPY IN THE CONTEMPORARY MANAGEMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC).BJU INTERNATIONAL. VOL. 116. ISSUE 1. P. 17 -29 55 73% 2
10 PETRIOLI, R , FIASCHI, AI , FRANCINI, E , PASCUCCI, A , FRANCINI, G , (2008) THE ROLE OF DOXORUBICIN AND EPIRUBICIN IN THE TREATMENT OF PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATE CANCER.CANCER TREATMENT REVIEWS. VOL. 34. ISSUE 8. P. 710-718 57 77% 32

Classes with closest relation at Level 1


Rank Class id link
1 1876 ANDROGEN RECEPTOR//GEORGE WHIPPLE CANC//CASTRATION RESISTANT PROSTATE CANCER
2 25055 ESTRAMUSTINE BINDING PROTEIN//ESTRAMUSTINE//ESTROMUSTINE
3 1816 ANDROGEN DEPRIVATION THERAPY//BICALUTAMIDE//COMBINED ANDROGEN BLOCKADE
4 35026 M1B PROSTATE CANCER//BIOMARKER EPIDERMAL GROWTH FACTOR RECEPTOR EGFR//C ERB B 2 NEU GENE
5 13629 TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4
6 21262 BONE SCAN INDEX//BONE SCAN//SKELETAL ALKALINE PHOSPHATASE
7 9580 BONE PAIN PALLIATION//STRONTIUM 89//PAIN PALLIATION
8 31089 OSTEOBLASTIC METASTASIS//HUMAN BONE MARROW ENDOTHELIAL CELLS//CATTEDRA PATOL GEN
9 18138 SURAMIN//HT 29 D4 CELLS//SURAMIN ANALOGS
10 16384 MOL PATHOL ULTRASTRUCT//ENDOTHELIN AXIS//ZIBOTENTAN

Go to start page